Introduction
Navigating the FDA’s 510(k) premarket notification terrain requires a comprehensive understanding of the FDA’s classification system for medical devices. This system determines the most appropriate pathway to market based on the risk the devices pose to patients. Whether it’s through the 510(k) Premarket Notification, Pre-Market Approval (PMA), or the De Novo process, devices must undergo specific submissions to enter the U.S. market.
Distinguishing between FDA Cleared, FDA Approved, and Granted devices is crucial, as they reflect different levels of regulatory scrutiny and approval. The 510(k) process plays a vital role in clearing medical devices that demonstrate substantial equivalence to a legally marketed device. Conducting thorough research, analyzing the competitive landscape, and consulting the Summaries of Safety and Effectiveness Data (SSEDs) in the FDA’s 510(k) database are essential steps in this process.
Transparency in the submission process is also emphasized, as all comments and documents may become public. Navigating the FDA 510(k) Search is indispensable for regulatory professionals in the medical device industry, ensuring compliance and success in a highly regulated market.
What is the FDA 510(k) Search?
Navigating the FDA’s terrain requires a comprehensive understanding of the FDA’s classification system for medical devices, which is pivotal in determining the most appropriate pathway to market. The FDA classifies devices into three levels based on the risk they pose to patients, with each classification requiring a different type of submission—namely, , Pre-Market Approval (PMA), or the De Novo process.
For a device to enter the U.S. market, it must be (for Class I or II devices through the ), FDA Approved (for Class III devices through the PMA process), or Granted (for devices that successfully pass the De Novo process). It’s essential to distinguish between these terms, as they reflect different levels of regulatory scrutiny and approval.
The allows for the clearance of medical devices that demonstrate to a —a legally marketed device that serves as a comparison point. To establish this equivalence, it is crucial to conduct thorough research on the subject device, understanding its intended user base—whether clinicians, physicians, dentists, or patients—and carefully reviewing the instructions for use, including any warnings and precautions.
In collaboration with marketing teams, it’s also advisable to analyze the competitive landscape, examining research literature, clinical studies, and promotional materials of competitor devices. This helps in identifying potential s with similar intended uses and technological characteristics. Creating a comparative table to juxtapose your device with these predicates can be a useful tool.
Once potential predicates are identified, consulting the Summaries of Safety and Effectiveness Data (SSED) available in the FDA’s 510(k) database is a critical step. These summaries provide detailed information on the safety and effectiveness of approved devices and can guide the development of a robust 510(k) submission.
Moreover, the FDA underscores the importance of transparency in the submission process. Any comments or documents submitted to the FDA may be made public, so it is incumbent upon the submitter to ensure that no confidential or sensitive information is inadvertently disclosed. This level of diligence and understanding of the FDA’s processes and requirements is indispensable for regulatory professionals navigating the complex landscape of .
Why is the FDA 510(k) Search important?
Navigating the complexities of is a critical task for any seeking market entry in the United States. One of the key steps in this process is understanding the various classification levels assigned by the FDA, which are based on the potential risk to patients. These classifications determine the appropriate for a device, be it Premarket Notification (510(k)), , or the De Novo process, each with distinct requirements and implications for market access.
With a , manufacturers must demonstrate that their device is substantially equivalent to an existing device that has already been legally marketed – a process that confirms safety and effectiveness without the need for premarket approval. This is essential for devices that do not require the more rigorous PMA pathway, which is typically reserved for high-risk devices that have no previous predicate.
The FDA’s database is an invaluable resource for manufacturers to examine regulatory histories, indications for use, and technological characteristics of medical devices. Such information guides comparative analyses, underpins informed decision-making, and upholds the safety and effectiveness standards of new devices. As the industry evolves, and with the advent of digital health technologies, regulatory guidance continues to adapt, ensuring that innovation is not stifled while maintaining patient safety.
For those involved in the production and distribution of medical devices targeting the U.S. market, annual establishment registration with the FDA is mandatory. This includes listing devices and detailing activities performed on them, a process made more efficient through the FDA’s searchable databases. These databases, updated quarterly, include and Commitments (PMCs), providing transparency on ongoing and completed studies related to clinical safety and efficacy.
As the industry faces various obstacles, including regulatory challenges that can solidify the dominance of incumbent products, it is important to remember the lessons learned from other sectors. Similar to the strategic approaches taken by ride-sharing companies like Uber and Lyft to overcome market entry barriers, some s have effectively navigated the regulatory landscape by creating sufficient market demand, although this must be balanced against the imperative of patient safety.
In conclusion, the FDA 510(k) Search and related databases serve as a cornerstone for the medical device industry, offering critical insights essential for compliance and success in a highly regulated market.
Navigating the FDA 510(k) Search
Mastering the is a critical aspect of . Initiating this process by deeply understanding the device in question is paramount. This entails not just knowing the device’s function but also grasping the intricacies of its use—cautions, warnings, and the spectrum of users from clinicians to patients. It’s equally important to analyze the competitive landscape, which helps in identifying potential that share the same intended use and technological characteristics.
The insights gleaned from research literature, , and competitor marketing materials, such as brochures and labeling, are invaluable. They serve as a foundation for creating a comparative table that juxtaposes your device against existing ones. The FDA’s database is an indispensable resource here, offering access to (Seeds), which are crucial for evaluating the similarities and differences among devices.
With the , the selection of an appropriate predicate device has become a nuanced process. It involves confirming that the potential predicate is not just legally marketed but also shares the same intended use without raising new safety or efficacy concerns due to differing technological characteristics.
The FDA, integral to public health, sets standards for the safety, efficacy, and security of medical devices. Their recent draft guidance, released in September 2023, underscores their commitment to streamlining the review process and ensuring that older predicates, with their extensive safety data, are utilized effectively.
In practice, utilizing the means employing all available filters—product code, device class, clearance date—and keywords to refine your search. Advanced search functionalities are also at your disposal to yield more precise results. However, it’s the preliminary groundwork of understanding both the device and its context in the market that transforms a simple search into a strategic component of device approval.
Understanding the Search Results
Utilizing the yields a list of that align with specified search parameters. This encompasses essential data like the device’s designation, its manufacturing entity, date of clearance, and its recommended applications. For a more granular perspective, one can delve into individual device entries to unearth comprehensive details, such as the , the associated FDA product code, and supplementary materials or documentation that support the device’s approval.
The importance of and its application cannot be overstated, particularly for users such as clinicians, physicians, dentists, and patients. Equally critical is acquiring knowledge about the competitive environment of the device, which involves examining a plethora of resources, including research papers, , and marketing materials. This aids in identifying analogous predicate devices featuring similar technological characteristics and intended uses, ultimately facilitating the construction of a comparative analysis table.
Moreover, the FDA’s role extends beyond the database, as it ensures the safety, efficacy, and security of various health-related products, impacting public health on multiple fronts. For those intent on submitting public comments regarding devices, caution is advised to avoid including personal or confidential data that is not intended for public disclosure. The FDA’s guidance on comment submission is a testament to its commitment to transparency and public engagement.
In the realm of healthcare innovation, the (CDER) plays a pivotal role in ushering new therapeutic options to the market, providing clear guidelines on study designs and data requirements for drug applications. This is crucial for the advancement of healthcare, offering novel treatments that address unmet medical needs. An annual compilation of newly approved molecular entities and therapeutic biological products is testament to CDER’s significant contribution to medical progress.
Analyzing the 510(k) Summary
A crucial aspect of the FDA is the , which is pivotal in the FDA’s public database. This summary is not merely an overview; it’s an essential comparison tool that delineates the similarities and differences between the new and a previously cleared predicate device. To truly comprehend a device’s safety, efficacy, and technological attributes, one must delve into the (SSEDs), which provide insights into clinical performance and user considerations, such as indications, contraindications, and warnings.
Understanding the is also beneficial. By analyzing research literature, , and competitor marketing materials, stakeholders can identify and forge a comparative analysis. This process is augmented by the FDA’s recent draft guidance on best practices for predicate selection, as part of its initiative to modernize the 510(k) review process. The guidance emphasizes the importance of confirming that a potential predicate is legally marketed and shares the same intended use without introducing new safety concerns due to different technological characteristics.
Moreover, the FDA’s Center for Drug Evaluation and Research (CDER) plays a fundamental role in ensuring the safety and effectiveness of new drugs and biological products, reflecting the agency’s dedication to advancing healthcare. These efforts underscore the meticulous scrutiny and regulatory oversight that goes into every reaching the market, safeguarding the well-being of the American public.
Navigating the FDA requires a keen understanding of . Identifying similar devices and comparing their technological characteristics is a fundamental step towards ensuring that a new device aligns with existing safety and effectiveness benchmarks. A thorough examination of the predicate device’s history, including its intended use and any improvements or alterations in technology, guides the developer in establishing a clear regulatory pathway for their device.
To illustrate, consider the case of a firm that recently revised its complaint coding and quality data analysis procedures. The firm is conducting a comprehensive review of historical complaints to ensure accurate coding, a process that is still underway. This reflects the meticulous nature of and the importance of precise documentation when it comes to FDA submissions.
For example, the FDA’s scrutiny of the Impella Connect System, which includes both software and hardware components, demonstrates the critical nature of software functions in medical device evaluation. The system’s alarm notifications and real-time case status displays are considered device functions that require premarket authorization.
The FDA’s further underscores the importance of strategic predicate selection. The initiative encourages the use of older predicates when they offer benefits, such as extensive safety data. A draft guidance document released on September 7, 2023, provides best practices for choosing a predicate, emphasizing the need for a legally marketed device with a similar intended use and technological profile that does not introduce new safety concerns.
Understanding the of the device in question is also crucial. The FDA categorizes medical devices into three distinct risk-based classes, each dictating a specific regulatory pathway—be it 510(k) Premarket Notification, Pre-Market Approval (PMA), or the De Novo process. The terminology—Registered, Cleared, Approved, and Granted—carries specific meanings and implications in the context of medical devices.
The FDA recently introduced a draft guidance detailing circumstances in which might be necessary for a 510(k) submission. This guidance elaborates on scenarios where non-clinical testing alone may not suffice to establish with a predicate device. Such scenarios include differences in indications for use or technological characteristics, situations where non-clinical testing cannot determine , or when new risks associated with the predicate device emerge.
Finally, the De Novo process stands as a pathway for novel devices without a legally marketed predicate. Success in the De Novo classification process not only classifies the device under a new regulatory category but also establishes it as a predicate for future submissions.
By delving into the intricacies of the 510(k) process and leveraging regulatory data, one can gain insights into the dynamics of medical device approval and the critical role of predicate device analysis in ensuring public health and safety.
Additional Resources and Databases
Beyond the FDA 510(k) Search tool, professionals seeking a deeper understanding of have access to several other critical resources. The FDA’s , for instance, is instrumental in providing up-to-date information on the latest that have been authorized for use. The Medical Device Recall database offers valuable insight into products that have been withdrawn from the market due to safety concerns, echoing the lessons from the 2018 documentary The Bleeding Edge, which highlighted the potential risks associated with fast-tracked devices lacking .
The is another important resource that collects reports of adverse events involving . This database supports the FDA’s post-market surveillance efforts, ensuring that any emerging issues with .
For those navigating the regulatory frameworks and classifications of , understanding the distinction between terms such as ‘Registered’, ‘Cleared’, ‘Approved’, and ‘Granted’ is crucial. Each term corresponds to a different status within the FDA’s approval process and determines how a device can be marketed and utilized within the US healthcare system.
Moreover, the alignment of data with the requirements of payors, such as CMS and private health plans, is a significant factor in the availability of to patients. The information necessary for FDA clearance may not always fulfill the criteria needed for coverage determinations, leading to potential delays or denials in patient access to new medical technologies.
Dr. Yukiko Nakatani from the WHO emphasizes the need for centralized information sources to aid global decision-makers in the selection and procurement of . The expansive range of , now exceeding 10,000 different types, and their varying levels of complexity necessitate a comprehensive database such as . This platform allows for streamlined access to information on , supporting healthcare systems from community to specialized hospitals, and facilitating improved patient outcomes, especially in resource-limited settings.
Navigating the plethora of and their regulatory status is a complex task. However, with the right tools and databases at their disposal, professionals in the field can ensure that they are making informed decisions that prioritize patient safety and the efficacy of medical technologies.
Conclusion
The FDA’s 510(k) premarket notification system is vital for medical device manufacturers entering the US market. Understanding the FDA’s classification system and different levels of regulatory scrutiny is crucial. Thorough research, competitive analysis, and consulting the FDA’s 510(k) database are essential steps.
The FDA 510(k) Search is indispensable for regulatory professionals, ensuring compliance and success. It allows clearance of devices demonstrating substantial equivalence to a legally marketed device. The database provides information on regulatory histories and technological characteristics, guiding comparative analyses.
Mastering the FDA 510(k) Search involves understanding the device, analyzing the competitive landscape, and utilizing search filters. The FDA’s database supports informed decision-making and upholds safety and effectiveness standards.
Additional resources like the Device Approvals and Clearances database and the Manufacturer and User Facility Device Experience (MAUDE) database provide valuable insights. Understanding terms like ‘Registered’, ‘Cleared’, ‘Approved’, and ‘Granted’ is crucial for marketing and utilization within the US healthcare system.
In conclusion, the FDA 510(k) Search and related resources are vital for the medical device industry. Navigating FDA regulations, understanding classification levels, and utilizing available tools are key to success and ensuring patient safety.
Explore the Device Approvals and Clearances database and the Manufacturer and User Facility Device Experience (MAUDE) database to gain valuable insights for your medical device success.
Frequently Asked Questions
What is the FDA 510(k) Search?
The FDA 510(k) Search is a tool used to navigate the FDA’s premarket notification process for medical devices. It allows for the clearance of Class I or II devices by demonstrating their substantial equivalence to an already legally marketed device.
Why is the FDA 510(k) Search important?
Understanding and utilizing the FDA 510(k) Search is important for medical device manufacturers seeking market entry in the U.S. It guides them in demonstrating that their device is substantially equivalent to an existing device, which is a requirement for devices that do not need the more rigorous PMA pathway.
What are the FDA’s classification levels for medical devices?
The FDA classifies devices into three levels based on the risk they pose to patients: Class I, II, and III. Each classification requires a different type of submission: 510(k) Premarket Notification for Class I or II, PMA for Class III, or the De Novo process for devices without a predicate.
How do you identify a potential predicate device for a 510(k) submission?
Potential predicate devices can be identified by analyzing the competitive landscape, researching literature, clinical studies, and reviewing promotional materials of similar devices. A comparative table juxtaposing your device against these predicates is useful, alongside consulting the FDA’s database for Summaries of Safety and Effectiveness Data (SSED).
What should be included in a 510(k) submission?
A 510(k) submission should include a thorough understanding of the subject device, a comparative analysis with predicate devices, and appropriate documentation that supports the device’s safety and effectiveness.
What is the significance of the FDA’s role in public health?
The FDA sets standards for the safety, efficacy, and security of medical devices, ensuring that new devices entering the market do not pose risks to public health. They provide databases and guidance to support informed decision-making and uphold safety standards.
How can you use the FDA 510(k) Search tool effectively?
To use the FDA 510(k) Search tool effectively, one should employ filters like product code, device class, clearance date, and keywords. Advanced search functionalities can also be used to yield precise results.
What is the De Novo process?
The De Novo process is a regulatory pathway for novel devices that do not have a legally marketed predicate. Success in the De Novo classification process classifies the device under a new regulatory category and establishes it as a predicate for future submissions.
What additional resources are available for understanding medical devices?
Additional resources include the FDA’s Device Approvals and Clearances database, the Medical Device Recall database, the MAUDE database for adverse event reports, and the WHO’s MeDevIS platform for global information on medical devices.
How does the FDA’s classification system affect the marketing and use of medical devices?
The FDA’s classification system affects the marketing and use of medical devices by determining the appropriate regulatory pathway and requirements for each device based on its risk level. Terms like ‘Registered,’ ‘Cleared,’ ‘Approved,’ and ‘Granted’ correspond to different statuses within the FDA’s approval process.
List of Sources
- What is the FDA 510(k) Search?
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-september-6-2024)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-october-20-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2024)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- federalregister.gov (https://www.federalregister.gov/documents/2023/12/21/2023-28095/510k-third-party-review-program-and-third-party-emergency-use-authorization-eua-review-draft)
- rimsys.io (https://www.rimsys.io/blog/fda-listed-cleared-approved-granted)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023)
- fda.gov (https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/completed-research-projects-office-prescription-drug-promotion-opdp-research)
- fda.gov (https://www.fda.gov/drugs/information-consumers-and-patients-drugs/overview-our-role-regulating-and-approving-drugs-video-series)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- Why is the FDA 510(k) Search important?
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-september-15-2023)
- accessdata.fda.gov (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm)
- infomeddnews.com (https://infomeddnews.com/tdb_templates/41424-2/)
- statnews.com (https://www.statnews.com/2024/03/22/medical-device-makers-fda-approval-uber/?utm_campaign=rss)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/fda-cleared-samd-by-the-numbers/)
- fda.gov (https://www.fda.gov/drugs/drug-approvals-and-databases/about-postmarketing-requirements-and-commitments-searchable-database)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- rimsys.io (https://www.rimsys.io/blog/fda-listed-cleared-approved-granted)
- Navigating the FDA 510(k) Search
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2024)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- federalregister.gov (https://www.federalregister.gov/documents/2023/12/21/2023-28095/510k-third-party-review-program-and-third-party-emergency-use-authorization-eua-review-draft)
- starfishmedical.com (https://starfishmedical.com/blog/using-the-fdas-best-practices-for-selecting-a-predicate-device/)
- fda.gov (https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/completed-research-projects-office-prescription-drug-promotion-opdp-research)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-july-11-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-november-21-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-october-20-2023)
- raps.org (https://www.raps.org/events/2023-nmpa-cfda-key-updates-and-look-ahead-on-2024?utm_campaign=webcast_chinanmpa_jan2024&utm_source=twitter&utm_medium=social)
- greenlight.guru (https://www.greenlight.guru/blog/recent-fda-draft-guidances)
- thefdalawblog.com (https://www.thefdalawblog.com/2023/10/when-should-a-510k-include-clinical-data/?utm_source=rss&utm_medium=rss&utm_campaign=when-should-a-510k-include-clinical-data)
- fda.gov (https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/division-standards-and-conformity-assessment)
- Understanding the Search Results
- statnews.com (https://www.statnews.com/2023/09/12/fda-prescription-information-one-pagers/?utm_campaign=rss)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- federalregister.gov (https://www.federalregister.gov/documents/2023/12/21/2023-28095/510k-third-party-review-program-and-third-party-emergency-use-authorization-eua-review-draft)
- federalregister.gov (https://www.federalregister.gov/documents/2024/08/08/2024-17515/flamingo-pharmaceuticals-ltd-proposal-to-withdraw-approval-of-two-abbreviated-new-drug-applications)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2022)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-november-21-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-july-11-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-october-20-2023)
- Analyzing the 510(k) Summary
- starfishmedical.com (https://starfishmedical.com/blog/using-the-fdas-best-practices-for-selecting-a-predicate-device/)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-october-20-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-july-11-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-november-21-2023)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2022)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023)
- forum.effectivealtruism.org (https://forum.effectivealtruism.org/posts/oSAbWDuxmFZnsGEvx/case-study-safety-standards-on-california-utilities-to)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- rimsys.io (https://www.rimsys.io/blog/fda-listed-cleared-approved-granted)
- dev.to (https://dev.to/nidhi_acharya_427558b1130/understanding-the-regulatory-framework-of-fda-for-drug-approval-3ebf)
- Utilizing the Predicate Device Information
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-march-15-2024)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-october-20-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-july-11-2023)
- rimsys.io (https://www.rimsys.io/blog/fda-listed-cleared-approved-granted)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- nature.com (https://www.nature.com/articles/s41746-024-01021-y)
- starfishmedical.com (https://starfishmedical.com/blog/using-the-fdas-best-practices-for-selecting-a-predicate-device/)
- thefdalawblog.com (https://www.thefdalawblog.com/2023/10/when-should-a-510k-include-clinical-data/?utm_source=rss&utm_medium=rss&utm_campaign=when-should-a-510k-include-clinical-data)
- fda.gov (https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/abiomed-inc-663150-09192023)
- fda.gov (https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/exactech-inc-669904-01192024)
- medtechintelligence.com (https://medtechintelligence.com/feature_article/510k-submission-planning/)
- starfishmedical.com (https://starfishmedical.com/blog/using-the-fdas-best-practices-for-selecting-a-predicate-device/)
- Additional Resources and Databases
- wcedmisten.fyi (https://wcedmisten.fyi/post/medical-device-analysis/)
- starfishmedical.com (https://starfishmedical.com/blog/using-the-fdas-best-practices-for-selecting-a-predicate-device/)
- fda.gov (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-november-21-2023)
- fda.gov (https://www.fda.gov/news-events/press-announcements/fda-roundup-february-16-2024)
- news-medical.net (https://www.news-medical.net/news/20240708/WHO-launches-an-online-platform-for-information-on-medical-devices.aspx)
- fda.gov (https://www.fda.gov/about-fda/cdrh-innovation/medical-device-coverage-initiatives-connecting-payors-payor-communication-task-force)
- rimsys.io (https://www.rimsys.io/blog/fda-listed-cleared-approved-granted)
- fda.gov (https://www.fda.gov/about-fda/cdrh-innovation/medical-device-coverage-initiatives-connecting-payors-payor-communication-task-force)
- gao.gov (https://www.gao.gov/products/gao-24-106699?utm_medium=social&utm_source=twitter&utm_campaign=usgao)
- medicaldevice-network.com (https://www.medicaldevice-network.com/sponsored/reducing-medical-device-approval-times-in-2023/)
